NASDAQ
Enanta Pharmaceuticals, Inc. (ENTA) reported revenue of $65.32M and net income of $-81,889,000 for FY 2025, with a net profit margin of -125.4%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.
No price data available for this timeframe.